[1]
|
Moscato, E.H., Peng, X., Jain, A., et al. (2014) Acute Mechanisms Underlying Antibody Effects in An-ti-N-methyl-D-aspartate Receptor Encephalitis. Annals of Neurology, 76, 108-119. https://doi.org/10.1002/ana.24195
|
[2]
|
Hughes, E.G., Peng, X., Gleichman, A.J., et al. (2010) Cellular and Synap-tic Mechanisms of Anti-NMDA Receptor Encephalitis. Journal of Neuroscience, 30, 5866-5875. https://doi.org/10.1523/JNEUROSCI.0167-10.2010
|
[3]
|
Cull-Candy, S., Brickley, S. and Farrant, M. (2001) NMDA Receptor Subunits: Diversity, Development and Disease. Current Opinion in Neurobiology, 11, 327-335. https://doi.org/10.1016/S0959-4388(00)00215-4
|
[4]
|
Wei, F., Yan, L.M., Su, T., et al. (2017) Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy. Neuroscience Bulletin, 33, 455-477. https://doi.org/10.1007/s12264-017-0134-1
|
[5]
|
Patel, K.H., Chowdhury, Y., Shetty, M., et al. (2020) Anti-N-methyl-d-aspartate Receptor Encephalitis Related Sinus Node Dysfunction and the Lock-Step Phenomenon. American Journal of Medical Case Reports, 8, 503-507.
https://doi.org/10.12691/ajmcr-8-12-20
|
[6]
|
Dutra, L.A., Abrantes, F., Toso, F.F., et al. (2018) Autoimmune En-cephalitis: A Review of Diagnosis and Treatment. Arquivos de Neuro-Psiquiatria, 76, 41-49. https://doi.org/10.1590/0004-282x20170176
|
[7]
|
Dalmau, J., Geis, C. and Graus, F. (2017) Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physi-ological Reviews, 97, 839-887.
https://doi.org/10.1152/physrev.00010.2016
|
[8]
|
Titulaer, M.J., Mccracken, L., Gabilondo, I., et al. (2013) Treat-ment and Prognostic Factors for Long-Term Outcome in Patients with Anti-NMDA Receptor Encephalitis: An Observa-tional Cohort Study. The Lancet Neurology, 12, 157-165. https://doi.org/10.1016/S1474-4422(12)70310-1
|
[9]
|
Chen, T.S., Lai, M.C., Huang, H.I., et al. (2022) Immunity, Ion Channels and Epilepsy. International Journal of Molecular Sciences, 23, Article No. 6446. https://doi.org/10.3390/ijms23126446
|
[10]
|
Britton, J. (2016) Chapter 13-Autoimmune Epilepsy. In: Pittock, S.J. and Vincent, A., Eds., Handbook of Clinical Neurology, Vol. 133, 219-245. https://doi.org/10.1016/B978-0-444-63432-0.00013-X
|
[11]
|
Britton, J. (2016) Autoimmune Epilepsy. In: Hand-book of Clinical Neurology, Vol. 133, Elsevier, Amsterdam, 219-245. https://doi.org/10.1016/B978-0-444-63432-0.00013-X
|
[12]
|
Van Sonderen, A., Petit-Pedrol, M., Dalmau, J., et al. (2017) The Value of LGI1, Caspr2 and Voltage-Gated Potassium Channel Antibodies in Encephalitis. Nature Reviews Neurology, 13, 290-301. https://doi.org/10.1038/nrneurol.2017.43
|
[13]
|
Wang, Y., Yu, Y., Hu, Y., et al. (2020) Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis. Frontiers in Neurology, 11, Article No. 280.
https://doi.org/10.3389/fneur.2020.00280
|
[14]
|
Sagane, K., Ishihama, Y. and Sugimoto, H. (2008) LGI1 and LGI4 Bind to ADAM22, ADAM23 and ADAM11. International Journal of Biological Sciences, 4, 387-396. https://doi.org/10.7150/ijbs.4.387
|
[15]
|
Lancaster, E., Huijbers, M.G., Bar, V., et al. (2011) Investigations of caspr2, an Autoantigen of Encephalitis and Neuromyotonia. Annals of Neurology, 69, 303-311. https://doi.org/10.1002/ana.22297
|
[16]
|
Fukata, Y., Lovero, K.L., Iwanaga, T., et al. (2010) Disruption of LGI1-Linked Synaptic Complex Causes Abnormal Synaptic Transmission and Epilepsy. Proceedings of the National Academy of Sciences of the United States of America, 107, 3799-3804. https://doi.org/10.1073/pnas.0914537107
|
[17]
|
Gaspard, N. (2016) Autoimmune Epilepsy. Continuum (Minneap Minn), 22, 227-245.
https://doi.org/10.1212/CON.0000000000000272
|
[18]
|
Zhou, Y.D., Lee, S., Jin, Z., et al. (2009) Arrested Matura-tion of Excitatory Synapses in Autosomal Dominant Lateral Temporal Lobe Epilepsy. Nature Medicine, 15, 1208-1214. https://doi.org/10.1038/nm.2019
|
[19]
|
Ohkawa, T., Fukata, Y., Yamasaki, M., et al. (2013) Autoantibodies to Epi-lepsy-Related LGI1 in Limbic Encephalitis Neutralize LGI1-ADAM22 Interaction and Reduce Synaptic AMPA Recep-tors. Journal of Neuroscience, 33, 18161-1874.
https://doi.org/10.1523/JNEUROSCI.3506-13.2013
|
[20]
|
Seagar, M., Russier, M., Caillard, O., et al. (2017) LGI1 Tunes Intrinsic Excitability by Regulating the Density of Axonal Kv1 Channels. Proceedings of the National Academy of Sciences of the United States of America, 114, 7719-7724. https://doi.org/10.1073/pnas.1618656114
|
[21]
|
Lancaster, E. and Dalmau, J. (2012) Neuronal Autoantigens—Pathogenesis, Associated Disorders and Antibody Testing. Nature Reviews Neurology, 8, 380-390. https://doi.org/10.1038/nrneurol.2012.99
|
[22]
|
Wang, M., Cao, X., Liu, Q., et al. (2017) Clinical Features of Limbic Encephalitis with LGI1 Antibody. Neuropsychiatric Disease and Treatment, 13, 1589-1596. https://doi.org/10.2147/NDT.S136723
|
[23]
|
Irani, S.R., Michell, A.W., Lang, B., et al. (2011) Faci-obrachial Dystonic Seizures Precede LGI1 Antibody Limbic Encephalitis. Annals of Neurology, 69, 892-900. https://doi.org/10.1002/ana.22307
|
[24]
|
Irani, S.R., Stagg, C.J., Schott, J.M., et al. (2013) Faciobrachial Dystonic Seizures: The Influence of Immunotherapy on Seizure Control and Prevention of Cognitive Impairment in a Broadening Phenotype. Brain, 136, 3151-3162.
https://doi.org/10.1093/brain/awt212
|
[25]
|
Van Sonderen, A., Thijs, R.D., Coenders, E.C., et al. (2016) Anti-LGI1 Encephalitis: Clinical Syndrome and Long-Term Follow-Up. Neurology, 87, 1449-1456. https://doi.org/10.1212/WNL.0000000000003173
|
[26]
|
Benarroch, E.E. (2012) GABAB Receptors: Structure, Functions, and Clinical Implications. Neurology, 78, 578-584.
https://doi.org/10.1212/WNL.0b013e318247cd03
|
[27]
|
Brown, J.T., Davies, C.H. and Randall, A.D. (2007) Syn-aptic Activation of GABA(B) Receptors Regulates Neuronal Network Activity and Entrainment. European Journal of Neuroscience, 25, 2982-2990.
https://doi.org/10.1111/j.1460-9568.2007.05544.x
|
[28]
|
Beghi, E., Giussani, G. and Sander, J.W. (2015) The Natu-ral History and Prognosis of Epilepsy. Epileptic Disorders, 17, 243-253. https://doi.org/10.1684/epd.2015.0751
|
[29]
|
Mckay, J.H., Dimberg, E.L. and Lopez Chiriboga, A.S. (2019) A Sys-tematic Review of Gamma-Aminobutyric Acid Receptor Type B Autoimmunity. Neurologia i Neurochirurgia Polska, 53, 1-7.
https://doi.org/10.5603/PJNNS.a2018.0005
|
[30]
|
Hoftberger, R., Titulaer, M.J., Sabater, L., et al. (2013) Encephali-tis and GABAB Receptor Antibodies: Novel Findings in a New Case Series of 20 Patients. Neurology, 81, 1500-1506. https://doi.org/10.1212/WNL.0b013e3182a9585f
|
[31]
|
Lancaster, E., Lai, M., Peng, X., et al. (2010) Antibodies to the GABA(B) Receptor in Limbic Encephalitis with Seizures: Case Series and Characterisation of the Antigen. The Lan-cet Neurology, 9, 67-76.
https://doi.org/10.1016/S1474-4422(09)70324-2
|
[32]
|
Bettler, B., Kaupmann, K., Mosbacher, J. and Gassmann, M. (2004) Molecular Structure and Physiological Functions of GABAB Receptors. Physiological Reviews, 84, 835-867. https://doi.org/10.1152/physrev.00036.2003
|